Researchers at Imperial College London are currently recruiting to the I HART CGM study, which aims to measure the impact of continuous glucose monitoring (CGM) on hypoglycaemia in people with Type 1 diabetes who have a reduced awareness of hypoglycaemia. I HART stands for Impact on Hypoglycaemia Awareness of Real Time CGM.
Participants need to be aged 18 or over, have had Type 1 diabetes for three or more years, and be treated with insulin injections. They also need to have either experienced a severe hypoglycaemic event in the last 12 months or have reduced awareness of hypoglycaemia.
Says Dr Nick Oliver, who is running the study, “We are recruiting people at highest risk of hypoglycaemia so are only recruiting people on MDI who have impaired hypoglycaemia awareness or who have had a severe hypoglycaemia requiring assistance to treat in the last 12 months. We see people for a screening visit and if they are eligible they are randomised to Dexcom G5 or Freestyle Libre. We set them up with the technology then speak to them on the phone after two weeks and see them in the research clinic after four and eight weeks. All participants are then offered an 8-week extension using G5.”
Anyone interested email Dr Nick Oliver at nick.oliver@imperial.ac.uk
This news item first appeared in Desang Diabetes Magazine, our free-to-receive digital journal. We cover diabetes news, diabetes management equipment (diabetes kit) and news about food suitable for a diabetic diet. Go to the top of this page to sign up – we just need your email address.
